Early- or mid-trimester amniocentesis biomarkers for predicting preterm delivery: a meta-analysis

References

• Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 2016;21:68–73.
   PubMed Web of Science ®Google Scholar
• Matthews TJ, MacDorman MF. Infant mortality statistics from the 2010 period linked birth/infant death data set. Natl Vital Stat Rep. 2013;62:1–26.
   Google Scholar
• Georgiou HM, Di Quinzio MK, Permezel M, Brennecke SP. Predicting preterm labour: current status and future prospects. Dis Markers. 2015;2015:435014.
   PubMed Web of Science ®Google Scholar
• Vinturache AE, Gyamfi-Bannerman C, Hwang J, Mysorekar IU, Jacobsson B, Preterm Birth International Collaborative (PREBIC). Maternal microbiome - A pathway to preterm birth. Semin Fetal Neonatal Med. 2016;21:94–9.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG. 2011;118:1042–54.
   PubMed Web of Science ®Google Scholar
• Brou L, Almli LM, Pearce BD, Bhat G, Drobek CO, Fortunato S, et al. Dysregulated biomarkers induce distinct pathways in preterm birth. BJOG. 2012;119:458–73.
   PubMed Web of Science ®Google Scholar
• Ghidini A, Jenkins CB, Spong CY, Pezzullo JC, Salafia CM, Eglinton GS. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol. 1997;37:227–31.
   PubMed Web of Science ®Google Scholar
• Cháfer-Pericás C, Stefanovic V, Sánchez-Illana Á, Escobar J, Cernada M, et al. Novel biomarkers in amniotic fluid for early assessment of intraamniotic infection. Free Radic Biol Med. 2015;89:734–40.
   PubMed Web of Science ®Google Scholar
• Hee L. Likelihood ratios for the prediction of preterm delivery with biomarkers. Acta Obstet Gynecol Scand. 2011;90:1189–99.
   PubMed Web of Science ®Google Scholar
• Lee SM, Park JS, Norwitz ER, Oh S, Kim EJ, Kim SM, et al. Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery intwins: a retrospective cohort study. J Perinatol. 2015;35:542–6.
   PubMed Web of Science ®Google Scholar
• Ozgu-Erdinc AS, Cavkaytar S, Aktulay A, Buyukkagnici U, Erkaya S, Danisman N. Mid-trimester maternal serum and amniotic fluid biomarkers for the prediction of preterm delivery and intrauterine growth retardation. J Obstet Gynaecol Res. 2014;40:1540–6.
   PubMed Web of Science ®Google Scholar
• Kim A, Lee ES, Shin JC, Kim HY. Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta. 2013;34:873–8.
   PubMed Web of Science ®Google Scholar
• La Sala GB, Ardizzoni A, Capodanno F, Manca L, Baschieri MC, Soncini E, et al. Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery. Int J Immunopathol Pharmacol. 2012;25:1029–40.
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Romero R, Bracalente G, Erez O, Dong Z, Hassan SS, et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med. 2012;40:329–43.
   PubMed Web of Science ®Google Scholar
• Bamberg C, Fotopoulou C, Thiem D, Roehr CC, Dudenhausen JW, Kalache KD. Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia. J Matern Fetal Neonatal Med. 2012;25:812–17.
   PubMed Web of Science ®Google Scholar
• Himaya E, Rhalmi N, Girard M, Tétu A, Desgagné J, Abdous B, et al. Midtrimester intra-amniotic sludge and the risk of spontaneous preterm birth. Am J Perinatol. 2011;28:815–20.
   PubMed Web of Science ®Google Scholar
• Thomakos N, Daskalakis G, Papapanagiotou A, Papantoniou N, Mesogitis S, Antsaklis A. Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2010;148:147–51.
   PubMed Web of Science ®Google Scholar
• Tarim E, Bağiş T, Kiliçdağ EB, Sezgin N, Yanik F. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery? J Perinat Med. 2005;33:524–9.
   PubMed Web of Science ®Google Scholar
• Biggio JR, Jr., Ramsey PS, Cliver SP, Lyon MD, Goldenberg RL, Wenstrom KD. Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes. Am J Obstet Gynecol. 2005;192:109–13.
   PubMed Web of Science ®Google Scholar
• Apuzzio J, Chan Y, Al-Khan A, Illsley N, Kim PL, Vonhaggen S. Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery. J Matern Fetal Neonatal Med. 2004;15:313–17.
   PubMedGoogle Scholar
• Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2001;185:1162–7.
   PubMed Web of Science ®Google Scholar
• Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol. 1998;178:546–50.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65–94.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2002. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
   Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
   PubMedGoogle Scholar
• Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. Available from: http://www.cochrane-handbook.org. Updated March, 2011.
   Google Scholar
• Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
   PubMed Web of Science ®Google Scholar
• Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878–88.
   PubMed Web of Science ®Google Scholar
• Chaemsaithong P, Romero R, Korzeniewski SJ, Martinez-Varea A, Dong Z, Yoon BH, et al. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection. J Matern Fetal Neonatal Med. 2016;29:360–7.
   PubMed Web of Science ®Google Scholar
• Weissenbacher T, Laubender RP, Witkin SS, Gingelmaier A, Schiessl B, Kainer F, et al. Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. Arch Gynecol Obstet. 2013;287:673–85.
   PubMed Web of Science ®Google Scholar
• Hsu TY, Lin H, Lan KC, Ou CY, Tsai CC, Cheng BH, et al. High interleukin-16 concentrations in the early second trimester amniotic fluid: an independent predictive marker for preterm birth. J Matern Fetal Neonatal Med. 2013;26:285–9.
   PubMed Web of Science ®Google Scholar
• Verma RP, Hansch C. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem. 2007;15:2223–68.
   PubMed Web of Science ®Google Scholar
• Sennstrom MB, Brauner A, Bystrom B, Malmstrom A, Ekman G. Matrix metalloproteinase-8 correlates with the cervical ripening process in humans. Acta Obstet Gynecol Scand. 2003;82:904–11.
   PubMed Web of Science ®Google Scholar
• Lee SE, Romero R, Jung H, Park CW, Park JS, Yoon BH. The intensity of the fetal inflammatory response in intraamniotic inflammation with and without microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 2007;197:294.e1–e6.
   PubMed Web of Science ®Google Scholar
• Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol. 2000;183:94–9.
   PubMed Web of Science ®Google Scholar
• Kim SM, Romero R, Lee J, Chaemsaithong P, Lee MW, Chaiyasit N, et al. About one-half of early spontaneous preterm deliveries can be identified by a rapid matrix metalloproteinase-8 (MMP-8) bedside test at the time of mid-trimester genetic amniocentesis. J Matern Fetal Neonatal Med. 2015;7:1–9.
   Google Scholar
• Rahkonen L, Rutanen EM, Nuutila M, Sainio S, Sorsa T, Paavonen J. Matrix metalloproteinase-8 in cervical fluid in early and mid pregnancy: relation to spontaneous preterm delivery. Prenat Diagn. 2010;30:1079–85.
   PubMed Web of Science ®Google Scholar
• Romero R, Jimenez C, Lohda AK, Nores J, Hanaoka S, Avila C, et al. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol. 1990;163:968–74.
   PubMed Web of Science ®Google Scholar
• Kirshon B, Rosenfeld B, Mari G, Belfort M. Amniotic fluid glucose and intraamniotic infection. Am J Obstet Gynecol. 1991;164:818–20.
   PubMed Web of Science ®Google Scholar
• Gauthier DW, Meyer WJ, Bieniarz A. Correlation of amniotic fluid glucose concentration and intraamniotic infection in patients with preterm labor or premature rupture of membranes. Am J Obstet Gynecol. 1991;165:1105–10.
   PubMed Web of Science ®Google Scholar
• Jia X. Value of amniotic fluid IL-8 and Annexin A2 in prediction of preterm delivery in preterm labor and preterm premature rupture of membranes. J Reprod Med. 2014;59:154–60.
   PubMed Web of Science ®Google Scholar
• Menon R, Bhat G, Saade GR, Spratt H. Multivariate adaptive regression splines analysis to predict biomarkers of spontaneous preterm birth. Acta Obstet Gynecol Scand. 2014;93:382–91.
   PubMed Web of Science ®Google Scholar